MannKind Corporation Reports 2016 Fourth Quarter and Full Year Financial Results
March 16, 2017 16:01 ET
|
MannKind
Conference Call to Begin Today at 5:00 PM ET VALENCIA, Calif., March 16, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today reported financial results for the fourth...
MannKind Corporation and Charles Mattocks Announce “REVERSED”-America’s First Docu-Series Tackling Diabetes
March 08, 2017 09:00 ET
|
MannKind
VALENCIA, Calif. and TAMPA, Fla., March 08, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation and Bella & Elle Media LLC announce MannKind’s sponsorship of “Reversed,” a production series aimed at...
MannKind Corporation Announces Upcoming Events
March 07, 2017 09:00 ET
|
MannKind
- 29th Annual ROTH Conference on March 13, 2017 -- 2016 Fourth Quarter and Full Year Financial Results Conference Call on March 16, 2017 - VALENCIA, Calif., March 07, 2017 (GLOBE NEWSWIRE) --...
MannKind Receives $16.7 Million From Sale of Valencia Property
February 21, 2017 09:00 ET
|
MannKind
VALENCIA, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today confirmed that it received $16.7 million on February 17, 2017, upon closing the sale of real...
MannKind Announces Launch of New Titration Pack and Field Force Expansion to Accelerate Afrezza® Growth
February 01, 2017 09:00 ET
|
MannKind
VALENCIA, Calif., Feb. 01, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD), a fully integrated biopharmaceutical company focusing on the discovery and development of...
MannKind Corporation to Hold Investor Conference Call on February 1, 2017
January 27, 2017 09:00 ET
|
MannKind
VALENCIA, Calif., Jan. 27, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) will host a conference call to discuss Company developments at 5:00 PM (Eastern Time) on February...
MannKind Receives $30.6 Million From Sanofi
January 09, 2017 09:00 ET
|
MannKind
VALENCIA, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today confirmed that it received $30.6 million from Sanofi on January 6, 2017, representing the...
CORRECTING AND REPLACING -- MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference
January 05, 2017 10:26 ET
|
MannKind
VALENCIA, Calif., Jan. 05, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD), please note that in the first...
MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference
January 05, 2017 09:00 ET
|
MannKind
VALENCIA, Calif., Jan. 05, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD), focused on the discovery and development of therapeutic products for diabetes, will present today...
MannKind Announces Key Addition to Its Executive Management Ranks
January 04, 2017 09:00 ET
|
MannKind
VALENCIA, Calif., Jan. 04, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today announced that Stuart A. Tross, Ph.D., has joined the company as its Chief People...